Most people with ALS die from respiratory failure. The disease progressively destroys the motor neurons that control the diaphragm and the muscles between the ribs, eventually making it impossible to breathe without assistance. The average survival after diagnosis is three to five years, though roughly 30% of people live five years or more, and 10 to 20% survive at least a decade.
Understanding the specific ways ALS leads to death can help patients and families prepare, make informed decisions about interventions, and know what to expect in the final stages.
Respiratory Failure: The Primary Cause
The diaphragm is the main muscle powering every breath you take. In ALS, the motor neurons that signal this muscle to contract gradually die off. As the diaphragm weakens, the body tries to compensate by relying on backup muscles in the neck, chest, and between the ribs. But ALS attacks those muscles too, and even at full strength they can’t do the diaphragm’s job for long.
The result is a slow buildup of carbon dioxide in the blood, a condition called hypercapnia. Early on, this tends to happen during sleep, especially when lying flat, because gravity removes the small mechanical advantage that sitting upright provides. People may notice morning headaches, persistent daytime fatigue, or feeling foggy and disoriented without understanding why. As the condition worsens, oxygen levels drop alongside rising carbon dioxide, and the body simply cannot exchange gases efficiently enough to sustain life.
In the final stage, rising carbon dioxide levels cause increasing drowsiness, confusion, and eventually loss of consciousness. Many clinicians and families describe this transition as relatively peaceful compared to other terminal processes, because the person gradually becomes sleepier rather than experiencing acute distress. Palliative medications can further ease any sensation of breathlessness or air hunger during this period.
Aspiration Pneumonia
ALS frequently weakens the muscles of the throat and tongue, a pattern called bulbar involvement. When these muscles can no longer coordinate swallowing properly, food, liquid, or saliva can slip into the airway instead of the esophagus. Research shows that even ALS patients without obvious bulbar symptoms already have measurable impairments in moving food from the mouth to the throat and clearing residue from the pharynx.
Repeated aspiration introduces bacteria into the lungs, causing pneumonia. In someone whose breathing muscles are already compromised, the lungs can’t mount an effective cough to clear the infection. Aspiration pneumonia is one of the most common immediate causes of death listed on death certificates for people with ALS, often working alongside the underlying respiratory muscle weakness to push the body past what it can recover from.
Malnutrition and Weight Loss
Difficulty swallowing doesn’t just risk pneumonia. It also makes eating exhausting and slow, which means caloric intake drops steadily as the disease progresses. At the same time, the body’s energy demands may actually increase. Muscle spasticity and constant involuntary twitching (fasciculations) burn extra calories, creating a widening gap between what the body needs and what it can take in.
This progressive weight loss and muscle wasting weakens the entire body, including the heart and the remaining respiratory muscles. Declining nutritional status is an independent predictor of shorter survival, meaning it accelerates death even beyond what the motor neuron loss alone would cause. A feeding tube can help close the calorie gap, but it doesn’t stop the underlying disease progression.
Sudden Cardiac Arrest
A less well-known cause of death in ALS involves the autonomic nervous system, which controls heart rhythm, blood pressure, and other involuntary functions. ALS can destroy neurons in the spinal cord that regulate sympathetic nerve signals to the heart. When these neurons are lost, the heart’s electrical timing becomes unstable.
In one study of 12 patients with pathologically confirmed ALS who were not on assisted ventilation, two died of sudden cardiac arrest caused by a dangerous heart rhythm called ventricular fibrillation. Those two patients had measurably fewer sympathetic neurons in the spinal cord and more abnormal heart rhythm patterns than the others. This is not the most common way people die from ALS, but it does account for some cases of unexpectedly sudden death, particularly in the later stages.
How Ventilation Changes the Timeline
Because respiratory failure is the primary killer, breathing support is the most significant intervention for extending life. Non-invasive ventilation, delivered through a mask, can ease symptoms and add months of survival. Many people with ALS use it initially just at night, then increasingly during the day as breathing muscles weaken further.
Invasive ventilation through a tracheostomy (a surgically placed breathing tube in the neck) can extend life substantially longer. The median survival after tracheostomy is about 21 months, with 65% of patients alive at one year and 45% at two years. Age matters: patients over 60 at the time of tracheostomy had roughly double the risk of dying compared to younger patients. Notably, quality-of-life scores for people on tracheostomy ventilation were similar to those of ALS patients not on ventilation and comparable to the general population, which challenges the assumption that life on a ventilator is necessarily diminished.
The decision about ventilation is deeply personal. A tracheostomy commits a person to round-the-clock care and dependence on machinery, and it does not slow the disease’s progression in other areas. Many people with ALS choose to decline invasive ventilation and instead focus on comfort-oriented care.
What the Final Days Look Like
In the terminal phase, most people with ALS experience increasing sleepiness as carbon dioxide accumulates. Early symptoms include headaches and mental fogginess, progressing to disorientation and then a state resembling deep sleep. The person typically loses consciousness before breathing stops entirely.
Palliative care teams manage discomfort during this period with medications that reduce the sensation of breathlessness and anxiety. Opioids and sedatives can be carefully adjusted to keep the person comfortable. If someone has been on mechanical ventilation and chooses to have it withdrawn, these same medications are used as continuous background infusions with additional doses available for any breakthrough distress.
In the Netherlands, where euthanasia is legal and well-documented, about 25% of ALS deaths between 2012 and 2020 involved euthanasia or physician-assisted dying. That figure rose from 17% in the mid-1990s to 40% in some later periods. Roughly 79% of ALS patients in that population chose some form of active end-of-life practice, reflecting how central the question of control over dying is for people living with this disease. In jurisdictions where medical aid in dying is available, ALS patients represent one of the most common groups to use it.